The Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development

BMC Developmental Biology

Volumn 11, Issue , 2011, Pages

  Poulsen, Ryan R ^a   McClaskey, Carolyn M ^a   Rivkees, Scott A ^a   Wendler, Christopher C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; FIBRONECTIN; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIUM CELL; HEART; HEART MUSCLE; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; PRENATAL DEVELOPMENT;

ANIMALS; CELL PROLIFERATION; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; FIBRONECTINS; HEART; LYSOPHOSPHOLIPIDS; MESENCHYMAL STEM CELLS; MICE; MYOCARDIUM; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 79958278811     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-11-37     Document Type: Article

References (43)

1. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. M Maceyka SG Payne S Milstien S Spiegel, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2002 1585 193 201 10.1016/S1388-1981(02)00341-4 (Pubitemid 36096858)
2. Sphingosine 1-phosphate signaling in mammalian cells. S Pyne N Pyne, Biochem J 2000 349 385 402 10.1042/0264-6021:3490385 10880336 (Pubitemid 30465772)
3. Sphingosine 1-Phosphate Inhibits Activation of Caspases that Cleave Poly(ADP-ribose) Polymerase and Lamins during Fas- and Ceramide-mediated Apoptosis in Jurkat T Lymphocytes. O Cuvillier DS Rosenthal ME Smulson S Spiegel, J Biol Chem 1998 273 2910 2916 10.1074/jbc.273.5.2910 9446602 (Pubitemid 28133941)
4. Sphingosine Kinase Mediates Vascular Endothelial Growth Factor-Induced Activation of Ras and Mitogen-Activated Protein Kinases. X Shu W Wu RD Mosteller D Broek, Mol Cell Biol 2002 22 7758 7768 10.1128/MCB.22.22.7758-7768.2002 12391145 (Pubitemid 35217287)
5. Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts. N Gellings Lowe JS Swaney KM Moreno RA Sabbadini, Cardiovasc Res 2009 82 303 12 19228708
6. International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature. J Chun EJ Goetzl T Hla Y Igarashi KR Lynch W Moolenaar S Pyne G Tigyi, Pharmacol Rev 2002 54 265 269 10.1124/pr.54.2.265 12037142 (Pubitemid 34575716)
7. Lysophospholipid Receptors. N Fukushima I Ishii JJ Contos JA Weiner J Chun, Annual Review of Pharmacology and Toxicology 2001 41 507 534 10.1146/annurev.pharmtox.41.1.507 11264467 (Pubitemid 32385897)
8. Sphingosine-1-phosphate receptor signalling in the heart. CK Means JH Brown, Cardiovasc Res 2009 82 193 200 19282351
9. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. AE Alewijnse SLM Peters MC Michel, Br J Pharmacol 143 6 666 684 15504747
10. Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. CC Wendler SA Rivkees, Dev Biol 2006 291 264 77 10.1016/j.ydbio.2005.12.013 16434032
11. Expression patterns of the lysophospholipid receptor genes during mouse early development. H Ohuchi A Hamada H Matsuda A Takagi M Tanaka J Aoki H Arai S Noji, Dev Dyn 2008 237 3280 94 10.1002/dvdy.21736 18924241
12. Sphingosine-1-phosphate receptors and the development of the vascular system. ML Allende RL Proia, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2002 1582 222 227 10.1016/S1388-1981(02)00175-0 (Pubitemid 34634133)
13. Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology. T Levade N Auge RJ Veldman O Cuvillier A Negre-Salvayre R Salvayre, Circ Res 2001 89 957 968 10.1161/hh2301.100350 11717151 (Pubitemid 34640861)
14. A sphingosine-1phosphate receptor regulates cell migration during vertebrate heart development. E Kupperman S An N Osborne S Waldron DYR Stainier, Nature 2000 406 192 195 10.1038/35018092 10910360 (Pubitemid 30469002)
15. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. Y Liu R Wada T Yamashita Y Mi CX Deng JP Hobson HM Rosenfeldt VE Nava SS Chae MJ Lee, et al. J Clin Invest 2000 106 951 961 10.1172/JCI10905 11032855
16. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. ML Allende T Yamashita RL Proia, Blood 2003 102 3665 3667 10.1182/blood-2003-02-0460 12869509 (Pubitemid 37409386)
17. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. JW Choi CW Lee J Chun, Biochim Biophys Acta 2008 1781 531 9 18407842
18. Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3. I Ishii X Ye B Friedman S Kawamura JJA Contos MA Kingsbury AH Yang G Zhang JH Brown J Chun, J Biol Chem 2002 277 25152 25159 10.1074/jbc.M200137200 12006579 (Pubitemid 34951821)
19. B2sphingosine 1-phosphate receptor in neuronal excitability. AJ MacLennan PR Carney WJ Zhu AH Chaves J Garcia JR Grimes KJ Anderson SN Roper N Lee, Eur J Neurosci 2001 14 203 209 10.1046/j.0953-816x.2001.01634.x 11553273 (Pubitemid 32777628)
20. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. M Kono Y Mi Y Liu T Sasaki ML Allende YP Wu T Yamashita RL Proia, J Biol Chem 2004 279 29367 73 10.1074/jbc.M403937200 15138255 (Pubitemid 38915815)
21. Incidence of congenital heart disease: I. Postnatal incidence. JI Hoffman, Pediatr Cardiol 1995 16 103 13 10.1007/BF00801907 7617503
22. Incidence of congenital heart disease: II. Prenatal incidence. JI Hoffman, Pediatr Cardiol 1995 16 155 65 7567659
23. Fate of the atrioventricular endocardial cushions in the developing chick heart. C Chin R Gandour-Edwards S Oltjen M Choy, Pediatric Research 1992 32 390 3 1437388
24. Morphogenesis of the truncus arteriosus of the chick embryo heart: The formation and migration of mesenchymal tissue. RP Thompson TP Fitzharris, Am J Anat 1979 154 545 55 10.1002/aja.1001540408 433796
25. A Field of Myocardial-Endocardial NFAT Signaling Underlies Heart Valve Morphogenesis. CP Chang JR Neilson JH Bayle JE Gestwicki A Kuo K Stankunas IA Graef GR Crabtree, Cell 2004 118 649 663 10.1016/j.cell.2004.08.010 15339668 (Pubitemid 39179716)
26. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Y Dor TD Camenisch A Itin G Fishman JA McDonald P Carmeliet E Keshet, Development 2001 128 1531 1538 11290292 (Pubitemid 32514837)
27. Molecular regulation of atrioventricular valvuloseptal morphogenesis. LM Eisenberg RR Markgald, Circulation Research 1995 77 1 6 7788867
28. Epithelial-Mesenchymal Transformation of Embryonic Cardiac Endothelial Cells is Inhibited by a Modified Antisense Oligodeoxynucleotide to Transforming Growth Factor {beta}3. J Potts J Dagle J Walder D Weeks R Runyan, PNAS 1991 88 1516 1520 10.1073/pnas.88.4.1516 1996351 (Pubitemid 21916256)
29. Cell biology of cardiac cushion development. AD Person SE Klewer RB Runyan, Int Rev Cytol 2005 243 287 335 15797462 (Pubitemid 41557302)
30. Developmental patterning of the myocardium. D Sedmera T Pexieder M Vuillemin RP Thompson RH Anderson, Anat Rec 2000 258 319 37 10.1002/(SICI)1097- 0185(20000401)258:4<319::AID-AR13.0.CO;2-O 10737851 (Pubitemid 30187458)
31. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists. S Mandala R Hajdu J Bergstrom E Quackenbush J Xie J Milligan R Thornton GJ Shei D Card C Keohane, et al. Science 2002 296 346 349 10.1126/science.1070238 11923495 (Pubitemid 34303689)
32. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation. J Fujishiro S Kudou S Iwai M Takahashi Y Hakamata M Kinoshita S Iwanami S Izawa T Yasue K Hashizume, et al. Transplantation 2006 82 804 12 17006328 (Pubitemid 44472474)
33. Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships. Y Koide T Hasegawa A Takahashi A Endo N Mochizuki M Nakagawa A Nishida, J Med Chem 2002 45 4629 38 10.1021/jm020080c 12361389
34. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. H Shimizu M Takahashi T Kaneko T Murakami Y Hakamata S Kudou T Kishi K Fukuchi S Iwanami K Kuriyama, et al. Circulation 2005 111 222 9 10.1161/01.CIR.0000152101.41037.AB 15642767 (Pubitemid 40139735)
35. Pleiotrophic actions of sphingosine-1phosphate. K Watterson H Sankala S Milstien S Spiegel, Prog Lipid Res 2003 42 344 357 10.1016/S0163-7827(03)00015-8 12790117
36. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors. V Brinkmann MD Davis CE Heise R Albert S Cottens R Hof C Bruns E Prieschl T Baumruker P Hiestand, et al. J Biol Chem 2002 277 21453 21457 10.1074/jbc.C200176200 11967257 (Pubitemid 34952287)
37. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. H Lie-Venema NM van den Akker NA Bax EM Winter S Maas T Kekarainen RC Hoeben MC deRuiter RE Poelmann AC Gittenberger-de Groot, ScientificWorldJournal 2007 7 1777 98 18040540 (Pubitemid 350277601)
38. Dual functions of [alpha]4[beta]1 integrin in epicardial development: initial migration and long-term attachment. JK Sengbusch W He KA Pinco JT Yang, J Cell Biol 2002 157 873 82 10.1083/jcb.200203075 12021259 (Pubitemid 34847824)
39. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Y Kono T Nishiuma Y Nishimura Y Kotani T Okada S Nakamura M Yokoyama, Am J Respir Cell Mol Biol 2007 37 395 404 10.1165/rcmb.2007-0065OC 17641298 (Pubitemid 47502714)
40. Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Q Zhang O Peyruchaud KJ French MK Magnusson DF Mosher, Blood 1999 93 2984 90 10216094 (Pubitemid 29200790)
41. Temporal and Distinct TGF[beta] Ligand Requirements during Mouse and Avian Endocardial Cushion Morphogenesis. TD Camenisch DGM Molin A Person RB Runyan AC Gittenberger-de Groot JA McDonald SE Klewer, Developmental Biology 2002 248 170 181 10.1006/dbio.2002.0731 12142029
42. Increased fibronectin deposition in embryonic hearts of retinol-binding protein-null mice. CC Wendler A Schmoldt GR Flentke LC Case L Quadro WS Blaner J Lough SM Smith, Circ Res 2003 92 920 8 10.1161/01.RES.0000069030.30886.8F 12663486 (Pubitemid 36542534)
43. A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. CC Wendler S Amatya C McClaskey S Ghatpande BB Fredholm SA Rivkees, Proc Natl Acad Sci USA 2007 104 9697 702 10.1073/pnas.0703557104 17522253 (Pubitemid 47175329)